I'm planning to cover RTA types 1, 2, and 4, walking through their pathophysiology, causes, and key lab findings like urine pH, serum potassium, and urine anion gap for a USMLE-style explanation. I also want to organize a comprehensive list of high-yield renal formulas — clearance, GFR, ERPF, FENa, anion gap, Winter's formula, corrected sodium/calcium, Cockcroft-Gault, Henderson-Hasselbalch, and acid-base compensation rules — before diving into defining RTA as a normal anion gap metabolic acidosis. For RTA specifically, all subtypes are non-anion gap acidoses, and I'm working through the urine anion gap logic: it's negative in diarrhea because NH4+ is excreted with chloride, but positive in RTA since the kidney can't properly excrete NH4+, particularly in types 1 and 4. Now I'm mapping out Type 1 (distal) RTA: the defect is failure of α-intercalated cells to secrete H+, leading to urine pH above 5.5 and hypokalemia since more K+ gets secreted to compensate for impaired H+ secretion. Serum bicarbonate tends to drop very low, under 10 mEq/L, making this the most severe of the three acidoses. Causes include amphotericin B, lithium, autoimmune diseases like Sjögren's, hereditary AE1 or H+-ATPase mutations, and sickle cell disease, with the main complication being calcium phosphate kidney stones from alkaline urine, hypercalciuria, and hypocitraturia. Nephrocalcinosis and childhood rickets/growth failure are further complications. Treatment relies on oral bicarbonate or potassium citrate, which fixes both acidosis and hypokalemia while inhibiting stone formation, and the urine anion gap here is positive. Now shifting to Type 2 (Proximal) RTA — this involves impaired bicarbonate reabsorption in the proximal tubule, whether from a defective Na+/H+ exchanger, carbonic anhydrase II deficiency, NBCe1 defect, or broader Fanconi syndrome, with urine pH staying below 5.5 once serum bicarbonate falls low enough. Once the serum bicarbonate reaches a new lower steady-state (12-20), the filtered load drops below the reabsorptive threshold, so the kidney reabsorbs it all and can acidify urine properly, though early on when bicarbonaturia is still occurring the urine pH exceeds 5.5. The classic distinction is urine pH < 5.5 in type 2 but > 5.5 if a bicarbonate load is given, and serum potassium tends to run low due to increased distal Na+ delivery driving K+ secretion, secondary hyperaldosteronism from volume depletion, and cation loss from bicarbonaturia — with hypokalemia often worsening once bicarbonate therapy starts. Causes span a broad range: Fanconi syndrome from generalized proximal tubule dysfunction, multiple myeloma via light chain toxicity, various drugs (carbonic anhydrase inhibitors, ifosfamide, tenofovir, cisplatin, expired tetracyclines), heavy metal toxicity, Wilson disease, cystinosis (the leading pediatric cause), tyrosinemia, galactosemia, hereditary fructose intolerance, glycogen storage disease type I, Lowe syndrome, and amyloidosis. Complications center on hypophosphatemic rickets/osteomalacia and growth failure — importantly, unlike type 1 RTA, nephrolithiasis is not typical since urine citrate and pH remain relatively normal, which is a key distinguishing feature. Treatment requires large bicarbonate doses (since much is lost in urine), potassium citrate, and thiazides to induce mild volume contraction that boosts proximal bicarbonate reabsorption. Now moving to Type 4 (hyperkalemic) RTA: this stems from aldosterone deficiency or resistance, reducing sodium reabsorption in collecting duct principal cells and impairing K+/H+ secretion, causing hyperkalemia. The resulting hyperkalemia then suppresses proximal tubule ammoniagenesis, cutting NH4+ excretion and net acid excretion, driving the acidosis. Urine pH is classically under 5.5 since distal H+ secretion still works but there's less buffer available. The hallmark is elevated serum K+, with only mildly reduced bicarbonate (usually 17-22 mEq/L). Common causes include aldosterone deficiency from Addison disease, congenital adrenal hyperplasia, or hyporeninemic hypoaldosteronism. Diabetic nephropathy is the most common cause in adults, along with chronic interstitial nephritis, NSAIDs, ACE inhibitors/ARBs, heparin, and direct renin inhibitors. Aldosterone resistance can stem from potassium-sparing diuretics, trimethoprim, pentamidine, calcineurin inhibitors, pseudohypoaldosteronism, obstructive uropathy, sickle cell disease, SLE, or tubulointerstitial disease — and the main complication to watch for is hyperkalemia itself. Treatment focuses on the underlying cause: fludrocortisone if aldosterone-deficient and not hypertensive, loop or thiazide diuretics for volume-overloaded/hypertensive patients, low-potassium diet, sodium bicarbonate, and stopping offending drugs — correcting the hyperkalemia restores ammoniagenesis and improves the acidosis. Urine anion gap is positive. Type 3 RTA is a mixed type 1/2 picture caused by carbonic anhydrase II deficiency, associated with osteopetrosis and cerebral calcifications. Now I'm building a comparison table contrasting the defect, urine pH, and serum potassium across the distal, proximal, and hyperkalemic RTA types. I'm filling in the causes for each RTA type—distal RTA from amphotericin, Sjögren, autoimmune disease, or hereditary factors; proximal RTA from Fanconi syndrome, myeloma, carbonic anhydrase inhibitors, or heavy metals; and type 4 RTA from diabetic nephropathy, Addison's, or medications like ACE inhibitors and NSAIDs. Now I'm thinking about a mnemonic to help remember these distinctions. For the diagnostic workup, I'd confirm a normal anion gap metabolic acidosis first, then use the urine anion gap — negative suggests GI loss like diarrhea, positive points to RTA. From there, serum potassium separates type 4 (high) from types 1/2 (low), and urine pH distinguishes type 1 (>5.5) from type 2 (<5.5), with a bicarb loading test as backup for type 2. The urine osmolal gap can also help estimate NH4+ excretion indirectly. Now I'm reviewing the key renal clearance formulas — how clearance compares to GFR tells you whether a substance is being net reabsorbed, secreted, or neither, and how inulin clearance serves as the gold standard for measuring GFR itself. Creatinine clearance is a practical clinical estimate but slightly overshoots true GFR since some creatinine gets secreted by the tubules. I'm also going through the Starling forces equation governing glomerular filtration rate, breaking down how glomerular capillary hydrostatic pressure and the opposing oncotic pressures shift with changes in afferent and efferent arteriolar tone. Rising Bowman's space pressure from obstruction opposes filtration, while dehydration or hypoalbuminemia alter oncotic pressure in opposite directions. I land on the net filtration pressure calculation, working through the arithmetic of glomerular capillary pressure minus Bowman's space pressure minus oncotic pressure to get the typical ~15 mmHg value. Creatinine and GFR track inversely but creatinine is an insensitive early marker since it doesn't rise noticeably until GFR drops substantially. Turning to effective renal plasma flow, I recall it's measured via PAH clearance, since PAH is filtered and actively secreted such that it's almost completely cleared in one pass, making its clearance a proxy for renal plasma flow. Since PAH extraction is only about 90%, true RPF is slightly higher than eRPF, so I'm noting the correction factor and normal values (~600-650 mL/min RPF). From there, renal blood flow follows by adjusting for hematocrit, giving normal values around 1000-1200 mL/min (roughly a quarter of cardiac output). Then filtration fraction is GFR/RPF, normally about 20%, and I'm starting to think through how afferent/efferent arteriolar changes shift this ratio. Working through each scenario: afferent constriction drops both GFR and RPF proportionally so FF stays the same, efferent constriction raises FF by boosting GFR while dropping RPF, efferent dilation lowers FF, afferent dilation raises both flows without changing FF, and plasma protein concentration changes affect GFR (and thus FF) without touching RPF at all. Ureteral obstruction lowers GFR and FF while leaving RPF unchanged, and dehydration causes RPF to drop sharply while GFR falls less, so FF actually rises -- this table is a First Aid classic worth memorizing cold. Now I'm moving into filtered load, which equals GFR times plasma concentration, using glucose as the example: filtered load = GFR × plasma glucose, with glucosuria kicking in around a plasma threshold of 200 mg/dL and the transport maximum reached near 375 mg/min. There's a splay region between the threshold and the true Tm because nephrons vary and SGLT2 saturation kinetics aren't uniform, and pregnancy raises GFR enough to outpace reabsorptive capacity, causing glucosuria and aminoaciduria at lower-than-normal thresholds. I'm also noting excretion rate as urine concentration times flow rate, and defining reabsorption and secretion rates as the difference between filtered load and excretion rate -- positive values mean net reabsorption, negative mean net secretion. Then I'm working through FENa, the fractional excretion of sodium, calculated from the ratio of sodium and creatinine clearances. A value below 1% points to prerenal azotemia where kidneys are avidly conserving sodium (with some exceptions like contrast nephropathy, acute glomerulonephritis, hepatorenal syndrome, early obstruction, and rhabdomyolysis), while above 2% suggests intrinsic renal damage like ATN where tubules can't reabsorb sodium properly, or later-stage postrenal obstruction. Since diuretics confound FENa, I note that FEUrea is a better alternative in that setting, along with other supportive markers like BUN/Cr ratio, urine sodium, urine osmolality, and urine specific gravity, each with their own cutoffs distinguishing prerenal from intrinsic causes. Then I move to free water clearance, defining osmolar clearance and showing how free water clearance equals urine flow adjusted by the ratio of urine to plasma osmolality, where a positive value indicates the kidney is excreting dilute urine. I'm working through what positive versus negative versus zero free water clearance means clinically — positive suggesting diabetes insipidus or water diuresis, negative suggesting SIADH or dehydration, and zero indicating isosthenuria such as with loop diuretics or chronic renal failure — and noting this all depends on ADH function and the kidney's diluting and concentrating mechanisms. I'm now moving into the anion gap section, starting with its formula as sodium minus the sum of chloride and bicarbonate. Normal AG ranges roughly 8-12 mEq/L, with some variation depending on whether potassium is included in the formula, and I'm noting the correction needed for hypoalbuminemia since low albumin falsely lowers the measured gap. I'm listing out the MUDPILES mnemonic for causes of high anion gap metabolic acidosis, covering methanol, uremia, diabetic and other ketoacidoses, propylene glycol, and iron or isoniazid toxicity. Continuing through the causes, I add lactic acidosis, ethylene glycol, and late salicylate toxicity, plus the alternative GOLDMARK mnemonic. Then I shift to normal-gap (hyperchloremic) acidosis, using HARDASS to cover hyperalimentation, Addison disease, renal tubular acidosis, diarrhea, acetazolamide, spironolactone, and saline infusion, noting that Addison's and spironolactone both relate to type 4 RTA mechanisms while acetazolamide causes type 2 RTA. I'm about to move into the delta-delta/delta ratio concept next. Urine anion gap distinguishes causes of NAGMA: negative UAG points to GI bicarbonate loss like diarrhea (kidney appropriately excreting NH4Cl), while positive UAG suggests renal tubular acidosis with impaired ammonium excretion. I'm noting the "neGUTive" mnemonic for GI causes before moving into Winter's formula for expected respiratory compensation. For metabolic acidosis, expected PaCO2 = 1.5 × [HCO3−] + 8 ± 2, with deviations indicating a mixed acid-base disorder — higher than expected means concurrent respiratory acidosis, lower means concurrent respiratory alkalosis. I'm also recalling the quick trick that PaCO2 should roughly match the last two digits of the pH, then moving into compensation expectations for the other primary disorders, starting with metabolic alkalosis where PaCO2 should rise. For respiratory alkalosis, HCO3- falls 2 mEq/L per 10 mmHg drop in PaCO2 acutely, or 4-5 chronically, and there's a rough pH shift of 0.08 per 10 mmHg acute versus 0.03 chronic. I'm also recalling the Henderson-Hasselbalch equation relating pH to the bicarbonate-to-PaCO2 ratio, with the simplified version for calculating [H+] directly from PaCO2. Then I'm noting the Kassirer-Bleich shortcut where pH 7.40 corresponds to [H+] of 40 nEq/L, verifiable with normal HCO3- and PaCO2 values, plus a quick trick of subtracting the pH's last two digits from 80. For serum osmolality, I'm recalling the calculated formula using sodium, glucose, and BUN, the normal range, and how effective osmolality excludes BUN since urea crosses membranes freely. Elevated osmolar gap points to unmeasured osmoles like toxic alcohols (methanol, ethylene glycol, isopropyl alcohol with its distinctive ketosis-without-acidosis), ethanol (with its correction factor), and other contributors like mannitol, glycine, or hyperlipidemia causing pseudohyponatremia. I'm also recalling the corrected sodium formula for hyperglycemia, adding 1.6 mEq/L per 100 mg/dL glucose above 100, with some using 2.4 for very high glucose levels. Hyperglycemia causes true dilutional hyponatremia by pulling water from cells, which is a distinct mechanism from lab-artifact pseudohyponatremia seen with hyperlipidemia or hyperproteinemia despite normal osmolality. For calcium correction with albumin, I add 0.8 mg/dL per 1 g/dL that albumin falls below 4 -- though this only affects total calcium, not ionized calcium, so measuring ionized Ca directly is more reliable, especially since pH also affects calcium binding to albumin. Now I'm working through free water deficit calculations for hypernatremia, using total body water estimates that vary by sex and age, and noting the importance of slow correction rates in both hyper- and hyponatremia to prevent cerebral edema or osmotic demyelination syndrome. I'm also covering the Adrogue-Madias formula for predicting sodium change per liter of infusate, then moving to Cockcroft-Gault for estimating creatinine clearance for drug dosing purposes, contrasting it with MDRD/CKD-EPI which are used for CKD staging based on GFR thresholds across stages G1 through G4. Then I'm working through the TTKG formula for assessing renal potassium handling — in hyperkalemia a low TTKG points to hypoaldosteronism while a higher value suggests an extrarenal cause, and in hypokalemia a TTKG above roughly 4 indicates renal potassium wasting. Since it's less commonly used now, I'm also considering spot urine potassium and urine K/Cr ratio thresholds as alternative ways to distinguish renal from extrarenal potassium loss. I'm also noting FEUrea for prerenal versus ATN when diuretics complicate the picture, and starting to think through fractional excretion of bicarbonate as another diagnostic ratio. Now I'm covering urine protein/creatinine and albumin/creatinine ratios for quantifying proteinuria severity, and moving into BUN/creatinine ratio as a marker distinguishing prerenal azotemia from other causes. For glucose handling, I'm noting the renal threshold (~200 mg/dL) and transport maximum (~375 mg/min) with splay accounting for nephron heterogeneity, then reviewing TF/P ratio patterns along the PCT for inulin, PAH, and freely filtered/reabsorbed solutes. ECF is measured by inulin or mannitol, TBW by D2O, ICF as TBW minus ECF, and interstitial as ECF minus plasma, with blood volume derived via plasma volume/(1−Hct); I recall the 60-40-20 rule for body water distribution. I'm also running through key normal values—GFR, RPF, RBF, filtration fraction, urine output, and segment-specific Na reabsorption percentages along the nephron. Now I'm noting that creatinine is inversely proportional to GFR, so halving GFR doubles serum creatinine, and steady-state production equals excretion. I'm also cataloging other relationships worth remembering: plasma osmolarity and ADH, urine-to-plasma osmolality ratios, specific gravity, net acid excretion (ammonium plus titratable acid minus bicarbonate), and the renal handling of daily acid load, plus osmotic diuresis and dipstick basics before moving into Kf and hydrostatic pressure concepts. Kf reflects hydraulic conductance in GFR = Kf × net filtration pressure, and it drops in diabetic nephropathy due to GBM thickening and reduced filtration surface. I'm also noting autoregulation via myogenic response and tubuloglomerular feedback aren't formula-based, adding the bicarbonate deficit formula for severe acidosis replacement, and the predicted pH shifts per PaCO2 change in acute versus chronic respiratory acidosis. Given how much ground this covers, I think I need to organize everything into a clear, structured answer. I want a teaching-style explanation with headings, tables, and mnemonics since the user wants to actually learn this, aiming for comprehensive coverage of both major topics without letting it get bloated—prioritizing the highest-yield formulas while keeping the lower-yield ones brief. I'm planning to start with renal tubular acidosis, covering the big picture of what RTA is and the core physiology of proximal tubule bicarbonate reabsorption. I'll flesh out the mechanisms of alpha-intercalated cell H+ secretion, ammoniagenesis, and aldosterone's role, then note the numbering convention before organizing each RTA type by defect, labs, causes, complications, and treatment, followed by a comparison table, a UAG-based diagnostic algorithm, and high-yield pearls before moving to the second topic. For that second part on renal formulas, I'm outlining the full set of sections: clearance and flow calculations, fractional excretions, water handling, acid-base formulas, osmolality calculations, and other key equations like Cockcroft-Gault, TTKG, and BUN/Cr ratios. I'm also planning to add a normal values cheat-sheet and a couple of short worked examples, like a fractional excretion calculation and Winter's formula, since those would be high-yield. I'm cross-checking key values against First Aid — confirming the normal anion gap range, Winter's formula, and the compensation rules for metabolic alkalosis and acute respiratory acidosis. I want to nail down the compensation formulas for chronic respiratory acidosis and both acute and chronic respiratory alkalosis, noting that different sources give slightly different coefficients so I'll flag that with First Aid's numbers as the primary reference. I'm also confirming the osmolality formula and the corrected sodium adjustment for hyperglycemia. Now I'm running through more renal physiology formulas: corrected calcium for albumin, Cockcroft-Gault creatinine clearance, FENa thresholds for prerenal versus intrinsic AKI, free water clearance, effective renal plasma flow via PAH clearance, renal blood flow from RPF and hematocrit, filtration fraction, and glucose reabsorption thresholds and transport maximum. I'm continuing with water deficit calculation using total body water and sodium ratio, delta ratio for interpreting mixed acid-base disorders, urine anion gap for distinguishing diarrhea from RTA, and typical bicarbonate ranges for the different RTA types. Type 4 and type 2 RTA both have urine pH under 5.5 while type 1 has pH above 5.5. Type 1 RTA leads to calcium phosphate stones from alkaline urine, hypercalciuria, and hypocitraturia, while type 2 RTA carries increased risk for hypophosphatemic rickets from Fanconi syndrome. Type 4 RTA develops through hyperkalemia suppressing ammonia synthesis in the proximal tubule, reducing ammonium excretion. I'm also recalling etiologies: type 1 stems from amphotericin B toxicity, analgesic nephropathy, obstructive urinary anomalies, or autoimmune disease like SLE or Sjögren's; type 2 arises from Fanconi syndrome, multiple myeloma, or carbonic anhydrase inhibitors; and type 4 results from reduced aldosterone production due to diabetic hyporeninism, ACE inhibitors, ARBs, NSAIDs, heparin, or cyclosporine. I should note Fanconi syndrome's features—wasting of bicarbonate, glucose, phosphate, amino acids, uric acid, and low-molecular-weight proteins—with causes including hereditary conditions (cystinosis, Wilson's, tyrosinemia, glycogen storage disease), ischemia, myeloma, and nephrotoxins like ifosfamide, cisplatin, tenofovir, expired tetracyclines, and lead. The hyperkalemic variant of type 1 RTA seen in sickle cell or obstruction feels too low-yield to include. I'm also working out how bicarbonate loading distinguishes type 1 from type 2 RTA: in type 2, fractional excretion of bicarbonate exceeds 15% once serum bicarb is normalized, while in type 1 the distal acidification defect keeps urine pH above 5.5 even during acidosis, with a blunted urine-blood PCO2 gradient after bicarbonate loading. I'll briefly note the ammonium chloride loading test for type 1, skip the voltage-dependent hyperkalemic distal RTA, and start jotting quick memory hooks like linking "distal" to failure to dump H+. Now I want to build memory hooks for type 2 (proximal, poor bicarb reabsorption, Fanconi/CA inhibitors/myeloma, low urine pH, rickets, big bicarb doses needed) and type 4 (hyperkalemia). Then I'll move into presenting the key renal formulas as compact cards with formula, normal value, and clinical pearl, alongside the filtration fraction table for afferent/efferent changes, the hyperbolic GFR-creatinine relationship showing early insensitivity, and a worked numeric example using plasma and urine concentrations to illustrate clearance calculations. For the worked examples, I'll walk through a clearance-versus-GFR comparison showing net reabsorption with a filtered load calculation, then an acid-base case applying Winter's formula to reveal a mixed respiratory-metabolic disorder, and finally an FF/RBF calculation using PAH and inulin clearances with hematocrit correction. I should also add a corrected sodium example with hyperglycemia, plus classic USMLE vignette patterns for RTA subtypes: Sjögren's with hypokalemic NAGMA pointing to type 1, amphotericin B exposure also suggesting type 1, and a child with Fanconi-like glucosuria/phosphaturia/aminoaciduria indicating type 2. Other high-yield triggers include acetazolamide or topiramate use, multiple myeloma, and cystinosis pointing to type 2, while elderly diabetics with mild hyperkalemia and low renin/aldosterone or patients on TMP-SMX/spironolactone/ACEi suggest type 4. I want to flag the key discriminator between RTA and diarrhea using urine anion gap—negative in diarrhea, positive in RTA—and note the classic trap distinguishing type 1 from type 2 despite both being hypokalemic. I'm also thinking through CKD-related acidosis: early CKD tends toward NAGMA from reduced ammoniagenesis (mimicking a hyperkalemic type 4 picture), while advanced CKD shifts to HAGMA from retained anions like sulfate, phosphate, urate, and hippurate. And I want to capture the mechanistic reasoning behind hypokalemia in type 1 RTA—impaired H+ secretion driving compensatory K+ loss, a defective H+/K+-ATPase, and secondary hyperaldosteronism from volume depletion—versus the bicarbonate-wasting mechanism in type 2. I'm planning to structure the rest as a clear diagnostic algorithm with headers, tables, and bullet points, keeping a teaching tone and aiming for a thorough but not overlong response given the scope of both topics plus the renal formulas. I'm also drafting a table showing how GFR, renal plasma flow, and filtration fraction change with various hemodynamic states. I should add dehydration to the table: GFR down, RPF down more, so filtration fraction rises. I'm also noting the net filtration pressure formula relating hydrostatic and oncotic pressures to GFR via Kf, and thinking about how comparing a substance's clearance to inulin's reveals whether it's net reabsorbed, secreted, or neither, plus the general fractional excretion formula. Now I'm running through normal physiologic values to have on hand — GFR, renal plasma flow, renal blood flow, filtration fraction, urine output, plasma osmolality, anion gap, and the standard acid-base and body water reference ranges. I'm mentally verifying more numbers: glucose threshold and Tm, nephron segment sodium reabsorption percentages, and deciding whether to briefly include lower-yield concepts like urine osmolal gap, bicarbonate deficit, Adrogue-Madias formula, and TTKG. I'm also double-checking specifics like the typical serum bicarbonate in Type 1 RTA to make sure my facts are accurate. Type 4 also has urine pH < 5.5 per First Aid. For causes, type 1 RTA is linked to amphotericin B, analgesic nephropathy, obstructive uropathy, and autoimmune diseases like SLE and Sjögren's, plus lithium and hereditary forms. Type 2 traces to Fanconi syndrome causes — Wilson disease, tyrosinemia, glycogen storage disease, lead poisoning, myeloma, and nephrotoxic drugs like ifosfamide, cisplatin, and tenofovir. Type 4 stems from decreased aldosterone (diabetic hyporeninism, ACEi/ARBs, NSAIDs, adrenal insufficiency) or aldosterone resistance. I'm also noting the complications: type 1 predisposes to calcium phosphate stones, while type 2 predisposes to hypophosphatemic rickets in Fanconi syndrome. Now I'm turning to what fraction of cardiac output renal blood flow represents. Corrected Ca uses 0.8×(4−albumin), water deficit is TBW×[(Na/140)−1], and Cockcroft-Gault holds. For renal failure workup, FENa <1% suggests prerenal while >2% points to intrinsic damage like ATN, with FEUrea thresholds of <35% and >50% serving similarly when diuretics confound FENa. TTKG helps distinguish hypoaldosteronism in hyperkalemia (TTKG <7) versus other causes in hypokalemia (TTKG >4). For hyperkalemia with high TTKG threshold I'll note the variability and flag it as lower-yield. The glucose Tm of 375 mg/min with a 200 mg/dL threshold is worth including, and I like the reciprocal creatinine-GFR relationship as a quick pearl (Cr 1→GFR 120, Cr 2→60, Cr 4→30, Cr 8→15). I'll also add a brief footnote on Type 3 RTA as carbonic anhydrase II deficiency, a mixed proximal/distal defect that's autosomal recessive and linked to osteopetrosis and cerebral calcifications. I'm also thinking about how to distinguish Type 1 from Type 4 RTA since both involve the distal nephron — the key differentiator is potassium level, with Types 1 and 2 causing hypokalemia versus Type 4 causing hyperkalemia. I want to include a simple memory trick for this rather than overcomplicating it with an awkward mnemonic. Now I'm structuring the actual answer: I'll open with the core framework definition — RTA as a normal anion gap hyperchloremic metabolic acidosis from a tubular defect in H⁺/HCO₃⁻ handling with preserved GFR — then move into details with markdown headers, tables, bolded key terms, worked examples, and a section on common exam traps, keeping table columns narrow so formatting doesn't break. I'm laying out the three core kidney jobs that map onto the three RTA types: reclaiming filtered bicarbonate in the proximal tubule (failure = Type 2), and secreting H⁺ distally via the α-intercalated cells' pumps and exchangers (failure = Type 1). Third, the kidney generates NH₃ from glutamine via ammoniagenesis to buffer secreted H⁺, and this needs aldosterone and normal potassium — hyperkalemia shuts it down, giving Type 4. Type 3 is a rare mixed carbonic anhydrase II deficiency with osteopetrosis, so boards jump straight from 2 to 4. Then I'm noting Type 1's defect: the α-intercalated cells fail to secrete H⁺, so urine can't be acidified and stays pH >5.5 despite systemic acidosis. Potassium runs low here since less H⁺ competes for secretion, so K⁺ gets dumped instead, and defective H⁺/K⁺-ATPase plus secondary hyperaldosteronism worsen this; bicarbonate can drop below 10, making it the most severe form. Causes include drugs like amphotericin B and lithium, autoimmune diseases like Sjögren's and lupus, hypercalciuria, obstruction, and hereditary transporter mutations, with complications centering on calcium phosphate stone formation. Now I'm noting the treatment approach—potassium citrate or bicarbonate to correct both the acidosis and the stone risk—before shifting to Type 2 proximal RTA, where the defect lies in reduced bicarbonate reabsorption in the proximal tubule, causing bicarbonate to spill into urine until serum levels reset at a lower steady state. Once that new baseline is reached, distal acidification still works normally, so urine pH drops below 5.5; giving alkali therapy paradoxically raises urine pH by causing bicarbonaturia, and a fractional excretion of bicarbonate above 15% after loading confirms the diagnosis. I'm also thinking through the potassium picture—hypokalemia develops from volume depletion-driven hyperaldosteronism and enhanced distal potassium secretion, and this actually worsens once bicarbonate treatment begins. Fanconi syndrome comes to mind as a key underlying cause, given its broader proximal tubule dysfunction. Causes span inherited disorders like cystinosis, Wilson disease, and various glycogen storage conditions, plus acquired etiologies like multiple myeloma light chains and drugs such as acetazolamide, tenofovir, and expired tetracyclines. Complications mainly involve hypophosphatemic bone disease rather than stones, since the urine stays acidic with normal citrate levels, and treatment requires much larger alkali doses than distal RTA to keep up with ongoing losses. Now I'm moving into Type 4 hyperkalemic RTA, tracing how reduced aldosterone action impairs ENaC-driven sodium reabsorption, which weakens the electrical gradient needed for potassium and hydrogen secretion — producing the hallmark hyperkalemia, which then drives intracellular alkalosis in proximal tubule cells that further suppresses ammoniagenesis. I'm noting the biochemical signature: urine pH stays under 5.5 since distal H⁺ pumping is preserved, bicarbonate is only mildly reduced, and potassium is markedly elevated as the key diagnostic clue. On causes, I'm starting with aldosterone deficiency, particularly hyporeninemic hypoaldosteronism from diabetic nephropathy as the most frequent etiology. For treatment, fludrocortisone if aldosterone-deficient (unless hypertensive/edematous, where loop/thiazide diuretics drive kaliuresis instead), plus NaHCO₃ — correcting the K⁺ restores ammoniagenesis and improves acidosis. I'm building a diagnostic algorithm for NAGMA: first confirm a normal anion gap, then use the urine anion gap to distinguish GI losses (negative UAG, "neGUTive") from RTAs (positive UAG, indicating the kidney itself is the problem). From there, serum K⁺ splits Type 4 (high) from Types 1/2 (low), and urine pH separates Type 1 (>5.5) from Type 2 (<5.5, with Fanconi features like glucosuria and phosphaturia, confirmed by FE HCO₃⁻ >15%). Now I'm moving into Part 2, laying out high-yield renal formulas covering clearance, GFR, eRPF, RBF, filtration fraction, and filtered load. I'm continuing this formula outline with excretion/reabsorption, Starling forces, and the GFR-creatinine relationship, then fractional excretions (FENa, FEUrea, FE-HCO₃), water balance calculations (free water clearance, TBW, deficits, Adrogue-Madias, correction rates), acid-base tools (anion gap, delta ratio, UAG, Winter's formula, compensation table), osmolality corrections, and miscellaneous formulas like Cockcroft-Gault, BUN/Cr ratio, UPCR/ACR, and TTKG. I'm also planning glucose threshold/Tm, fluid compartments, a normal values cheat sheet, worked examples, and common exam traps — writing everything out in full with clear plain-text formulas using Unicode subscripts for readability. # Part 1 — Renal Tubular Acidosis (RTA) ## The core concept RTA = **normal anion gap (hyperchloremic) metabolic acidosis** caused by a **tubular defect** in handling H⁺/HCO₃⁻, with a **relatively preserved GFR**. (Contrast: the acidosis of advanced CKD is from lost nephron mass and eventually becomes high-anion-gap.) The kidney has to do three jobs to keep you non-acidotic. Each RTA is a failure of one job: | Job | Where | Failure = | |---|---|---| | **Reclaim filtered HCO₃⁻** (~85% in PCT via Na⁺/H⁺ exchanger + carbonic anhydrase) | Proximal tubule | **Type 2** | | **Secrete H⁺** (α-intercalated cells: H⁺-ATPase, H⁺/K⁺-ATPase, basolateral AE1 Cl⁻/HCO₃⁻ exchanger) | Collecting duct | **Type 1** | | **Make NH₃ to carry H⁺ out** (ammoniagenesis from glutamine in PCT; suppressed by hyperkalemia; needs aldosterone effect) | PCT + CD | **Type 4** | *(Type 3 = carbonic anhydrase II deficiency — mixed 1+2 with osteopetrosis and cerebral calcifications. Extremely rare; that's why boards jump from 2 to 4.)* --- ## Type 1 — Distal RTA - **Defect:** α-intercalated cells can't secrete H⁺ → **urine cannot be acidified → urine pH > 5.5** even during systemic acidosis. - **K⁺: LOW.** H⁺ isn't available to balance Na⁺ reabsorption via ENaC, so K⁺ is secreted instead; H⁺/K⁺-ATPase (which normally reabsorbs K⁺) is dysfunctional; mild volume depletion → secondary hyperaldosteronism. - **HCO₃⁻: can be very low (<10)** — most severe of the three. - **Causes:** Amphotericin B, lithium, ifosfamide, analgesic nephropathy; autoimmune (**Sjögren**, SLE, RA); hypercalciuria/nephrocalcinosis; obstructive uropathy; hereditary (AE1 or H⁺-ATPase mutations); sickle cell disease. - **Complications:** **Calcium phosphate stones and nephrocalcinosis** — alkaline urine + hypercalciuria (bone buffers the acid, releasing Ca/PO₄) + hypocitraturia (acidosis ↑ PCT citrate reabsorption). Rickets/osteomalacia, growth failure in children. - **Treatment:** Oral alkali — **potassium citrate** (fixes acidosis + hypokalemia + inhibits stones) or NaHCO₃; modest doses (~1–2 mEq/kg/day) suffice. ## Type 2 — Proximal RTA - **Defect:** ↓ PCT HCO₃⁻ reabsorption → the "bicarbonate threshold" is lowered. HCO₃⁻ spills into urine until serum HCO₃⁻ falls to a new steady state (**~12–20 mEq/L**). At that point the reduced filtered load can be fully reabsorbed and the (intact) distal nephron acidifies the urine → **urine pH < 5.5**. If you give alkali, bicarbonaturia resumes and urine pH rises (**FE-HCO₃⁻ > 15% after bicarbonate loading is diagnostic**). - **K⁺: LOW.** Bicarbonaturia drags Na⁺ out → volume depletion → hyperaldosteronism; ↑ distal Na⁺ delivery with HCO₃⁻ as a non-reabsorbable anion → ↑ K⁺ secretion. **Hypokalemia worsens when you treat with bicarbonate.** - **Causes:** - **Fanconi syndrome** (global PCT failure: glucosuria with normal serum glucose, phosphaturia, aminoaciduria, uricosuria, low-MW proteinuria) — cystinosis (commonest inherited cause in kids), Wilson disease, tyrosinemia, hereditary fructose intolerance, galactosemia, glycogen storage disease I, Lowe syndrome - **Multiple myeloma** (light-chain toxicity), amyloidosis - Drugs: **carbonic anhydrase inhibitors (acetazolamide, topiramate)**, ifosfamide, cisplatin, **tenofovir**, expired tetracyclines, aminoglycosides - Heavy metals (lead, cadmium, mercury) - **Complications:** **Hypophosphatemic rickets/osteomalacia** (phosphaturia), growth failure. **Stones are NOT typical** (acid urine, normal citrate). - **Treatment:** **Large** alkali doses (10–15 mEq/kg/day — you're pouring it into a leaky bucket); K⁺ citrate; **thiazide** (mild volume contraction ↑ proximal HCO₃⁻ reabsorption); phosphate + vitamin D if Fanconi; treat the underlying cause. ## Type 4 — Hyperkalemic RTA (aldosterone deficiency or resistance) - **Defect:** ↓ aldosterone action on principal cells → ↓ ENaC Na⁺ reabsorption → less lumen-negative voltage → ↓ K⁺ and H⁺ secretion → **hyperkalemia**. Hyperkalemia then shifts K⁺ into PCT cells (H⁺ out) → intracellular alkalosis → **↓ ammoniagenesis → ↓ NH₄⁺ excretion**. The H⁺ pumps still work, but there's no buffer to carry acid out. - **Urine pH: < 5.5** (can acidify; just can't excrete enough total acid). - **K⁺: HIGH** — the defining feature. - **HCO₃⁻: mildly low (usually >17).** - **Causes:** - *Aldosterone deficiency:* **Diabetic nephropathy (hyporeninemic hypoaldosteronism — most common)**, chronic interstitial nephritis, **NSAIDs** (↓ renin), **ACEi/ARBs**, direct renin inhibitors, **heparin** (inhibits aldosterone synthesis), **Addison disease**, 21-hydroxylase deficiency (CAH) - *Aldosterone resistance:* **K⁺-sparing diuretics** (spironolactone, eplerenone, amiloride, triamterene), **trimethoprim**, pentamidine (ENaC blockers), **calcineurin inhibitors** (cyclosporine, tacrolimus), obstructive uropathy, sickle cell disease, SLE, pseudohypoaldosteronism type I - **Treatment:** Stop offending drugs, low-K⁺ diet, **fludrocortisone** if truly aldosterone-deficient (avoid if hypertensive/edematous → use a loop or thiazide diuretic to drive kaliuresis instead), NaHCO₃. Correcting K⁺ restores ammoniagenesis and improves the acidosis. --- ## Side-by-side comparison (memorize this) | Feature | Type 1 (Distal) | Type 2 (Proximal) | Type 4 (Hyperkalemic) | |---|---|---|---| | Defect | ↓ H⁺ secretion (α-intercalated cell) | ↓ HCO₃⁻ reabsorption (PCT) | ↓ aldosterone effect → ↑K⁺ → ↓ NH₄⁺ excretion | | **Urine pH** | **> 5.5** | **< 5.5** (>5.5 if given alkali) | **< 5.5** | | **Serum K⁺** | **↓** | **↓** | **↑** | | Serum HCO₃⁻ | Often < 10 (severe) | 12–20 (moderate) | > 17 (mild) | | Urine anion gap | Positive | Positive | Positive | | Stones / nephrocalcinosis | **Yes** (Ca phosphate) | No | No | | Bone disease | Rickets/osteomalacia | **Hypophosphatemic rickets** (Fanconi) | No | | Fanconi features | No | **Yes** | No | | Alkali needed | Small dose | **Large dose** (worsens hypoK) | Small dose + fix K⁺ | | Classic causes | Ampho B, Li, Sjögren, SLE, ifosfamide | Fanconi, myeloma, acetazolamide/topiramate, tenofovir | Diabetic nephropathy, Addison, ACEi/ARB, spironolactone, TMP, NSAIDs, heparin | **Memory hook:** Type **1** is the **one** with high urine pH. Types 1 & 2 → low K⁺; Type **4** → K⁺ goes **forth** (up). --- ## Diagnostic algorithm for normal-anion-gap metabolic acidosis 1. **Confirm normal AG:** Na⁺ − (Cl⁻ + HCO₃⁻) = 8–12. 2. **Urine anion gap = (U_Na + U_K) − U_Cl** - **Negative** → GI HCO₃⁻ loss (diarrhea) — **"neGUTive."** The kidney is appropriately dumping NH₄Cl (unmeasured cation NH₄⁺ drags measured Cl⁻ with it). - **Positive** → RTA — the kidney is failing to excrete NH₄⁺. 3. **Serum K⁺:** High → **Type 4**. Low → Type 1 or 2. 4. **Urine pH:** > 5.5 → **Type 1**. < 5.5 → **Type 2** (look for glucosuria with normal glucose, phosphaturia; confirm with FE-HCO₃⁻ > 15% after alkali load). ## Classic vignettes - Woman with dry eyes/dry mouth + hypokalemia + NAGMA + urine pH 6.5 + nephrocalcinosis → **Type 1 (Sjögren)** - On amphotericin B with hypoK, hypoMg, NAGMA → **Type 1** - Child with growth failure, rickets, glucosuria with normal serum glucose, aminoaciduria → **Fanconi → Type 2** (think cystinosis) - Migraine patient on topiramate, or glaucoma patient on acetazolamide → **Type 2** - Elderly diabetic with mild CKD, K⁺ 5.8, HCO₃⁻ 19, urine pH 5.0, low renin & aldosterone → **Type 4** - HIV patient on TMP-SMX develops hyperkalemia + mild acidosis → **Type 4** (TMP blocks ENaC) - Both RTA and diarrhea give NAGMA + hypoK — **only the UAG separates them** --- # Part 2 — High-Yield Renal Formulas ## A. Clearance and hemodynamics **1. Renal clearance** $$C_x = \frac{U_x \times V}{P_x}$$ (U_x = urine conc., V = urine flow rate, P_x = plasma conc.; units mL/min = volume of plasma "cleared" per minute) - C_x < GFR → net **reabsorption** (or not freely filtered) - C_x > GFR → net **secretion** - C_x = GFR → neither (inulin) **2. GFR** $$GFR = C_{inulin} = \frac{U_{in} \times V}{P_{in}}$$ - Inulin is the gold standard (freely filtered, not reabsorbed/secreted/metabolized). Normal ≈ **125 mL/min (~180 L/day)**. - **Creatinine clearance slightly overestimates GFR** (creatinine is a bit secreted). - Serum creatinine ∝ 1/GFR: Cr 1 → GFR ~120; Cr 2 → 60; Cr 4 → 30; Cr 8 → 15. Cr stays "normal" until ~50% of GFR is lost — an insensitive early marker. **3. Starling forces** $$GFR = K_f \times [(P_{GC} - P_{BS}) - (\pi_{GC} - \pi_{BS})]$$ - P_GC (favors filtration): ↑ with afferent dilation/efferent constriction; ↓ with afferent constriction (NSAIDs block PG-mediated afferent dilation) - P_BS (opposes): ↑ with obstruction (stone, BPH) - π_GC (opposes): ↑ with hemoconcentration; ↓ with hypoalbuminemia - π_BS ≈ 0 normally (no protein in Bowman's space) **4. Effective renal plasma flow** $$eRPF = C_{PAH} = \frac{U_{PAH} \times V}{P_{PAH}}$$ - PAH is filtered **and** actively secreted (PCT), so nearly all entering the kidney is excreted. Extraction ≈ 90% → **eRPF underestimates true RPF by ~10%**. Normal RPF ≈ 600–650 mL/min. **5. Renal blood flow** $$RBF = \frac{RPF}{1 - Hct}$$ Normal ≈ 1,000–1,200 mL/min (~20–25% of cardiac output). **6. Filtration fraction** $$FF = \frac{GFR}{RPF} \approx 20\%$$ | Change | GFR | RPF | FF | |---|---|---|---| | Afferent constriction (NSAIDs, ↑ sympathetic) | ↓ | ↓ | — | | Afferent dilation (prostaglandins) | ↑ | ↑ | — | | **Efferent constriction (angiotensin II)** | ↑ | ↓ | **↑** | | **Efferent dilation (ACEi/ARB)** | ↓ | ↑ | **↓** | | ↑ Plasma protein | ↓ | — | ↓ | | ↓ Plasma protein (nephrotic, cirrhosis) | ↑ | — | ↑ | | Ureteral obstruction | ↓ | — | ↓ | | Dehydration | ↓ | ↓↓ | ↑ | **7. Filtered load, excretion, reabsorption, secretion** - Filtered load = **GFR × P_x** - Excretion rate = **U_x × V** - Reabsorption rate = Filtered load − Excretion - Secretion rate = Excretion − Filtered load - Glucose: glucosuria begins at plasma ≈ **200 mg/dL** (threshold); SGLT2 saturated (Tm ≈ 375 mg/min) at plasma ≈ **375 mg/dL**. The gap between them = **splay**. Pregnancy ↑ GFR → glucosuria at lower plasma glucose. ## B. Fractional excretions $$FE_x (\%) = \frac{U_x \times P_{Cr}}{P_x \times U_{Cr}} \times 100 = \frac{C_x}{C_{Cr}}$$ - **FE_Na < 1%** → prerenal AKI (also contrast, hepatorenal, acute GN, rhabdo); **> 2%** → intrinsic (ATN). Unreliable on diuretics → use **FE_urea: < 35% prerenal, > 50% ATN**. - Supporting prerenal clues: BUN/Cr > 20, U_Na < 20, U_osm > 500, specific gravity > 1.020. - **FE_HCO₃⁻ > 15%** (after alkali load) → Type 2 RTA. ## C. Water handling **Free water clearance** $$C_{H_2O} = V - C_{osm} = V\left(1 - \frac{U_{osm}}{P_{osm}}\right)$$ - Positive (dilute urine) → excreting free water: DI, low ADH - Negative (concentrated urine) → retaining free water: SIADH, dehydration - Zero → isosthenuria (loop diuretics, advanced CKD) **Body fluid compartments (60-40-20 rule):** TBW = 60% weight (men; 50% women/elderly); ICF 40%; ECF 20% (interstitial 15%, plasma 5%). Plasma volume measured by radiolabeled albumin/Evans blue; ECF by inulin/mannitol; TBW by D₂O. **Free water deficit (hypernatremia)** $$\text{Deficit (L)} = TBW \times \left(\frac{Na^+}{140} - 1\right)$$ Correct Na⁺ no faster than **~10–12 mEq/L per 24 h** (cerebral edema). In hyponatremia, no faster than **8–10 mEq/L per 24 h** (osmotic demyelination). ## D. Acid–base **Anion gap** $$AG = Na^+ - (Cl^- + HCO_3^-) \quad (\text{normal } 8\text{–}12)$$ - Correct for albumin: **AG_corrected = AG + 2.5 × (4 − albumin)** - High AG: **MUDPILES** (Methanol, Uremia, DKA/ketoacidoses, Propylene glycol, Iron/INH, Lactate, Ethylene glycol, Salicylates) - Normal AG: **HARDASS** (Hyperalimentation, Addison, RTA, Diarrhea, Acetazolamide, Spironolactone, Saline) **Delta ratio (finding a hidden second disorder)** $$\Delta\text{ratio} = \frac{AG - 12}{24 - HCO_3^-}$$ - < 0.4 → pure NAGMA; 0.4–1 → mixed HAGMA + NAGMA; **1–2 → pure HAGMA**; **> 2 → HAGMA + metabolic alkalosis** (e.g., DKA with vomiting) **Urine anion gap** $$UAG = (U_{Na} + U_K) - U_{Cl}$$ Negative → diarrhea ("neGUTive"); Positive → RTA. **Winter's formula (expected PaCO₂ in metabolic acidosis)** $$PaCO_2 = 1.5 \times HCO_3^- + 8 \pm 2$$ - Measured > expected → concomitant respiratory acidosis - Measured < expected → concomitant respiratory alkalosis - Shortcut: PaCO₂ ≈ last two digits of pH (pH 7.25 → PaCO₂ ≈ 25) **Expected compensation for the others** | Disorder | Expected compensation | |---|---| | Metabolic alkalosis | PaCO₂ ↑ 0.7 per 1 ↑ HCO₃⁻ | | Acute respiratory acidosis | HCO₃⁻ ↑ 1 per 10 ↑ PaCO₂ | | Chronic respiratory acidosis | HCO₃⁻ ↑ 3.5–4 per 10 ↑ PaCO₂ | | Acute respiratory alkalosis | HCO₃⁻ ↓ 2 per 10 ↓ PaCO₂ | | Chronic respiratory alkalosis | HCO₃⁻ ↓ 4–5 per 10 ↓ PaCO₂ | (pH falls ~0.08 per 10 mmHg CO₂ rise if acute, ~0.03 if chronic.) **Henderson–Hasselbalch** $$pH = 6.1 + \log\frac{[HCO_3^-]}{0.03 \times PaCO_2} \qquad \text{or} \qquad [H^+]\,(nEq/L) = \frac{24 \times PaCO_2}{HCO_3^-}$$ (pH 7.40 ↔ [H⁺] 40; quick check: [H⁺] ≈ 80 − last two digits of pH) ## E. Osmolality and "corrected" values **Calculated serum osmolality** $$Osm = 2\,Na^+ + \frac{Glucose}{18} + \frac{BUN}{2.8} \quad (\text{normal } 275\text{–}295)$$ - Effective osmolality (tonicity) drops the BUN term (urea crosses membranes freely). - **Osmolar gap = measured − calculated; normal < 10.** Elevated → methanol, ethylene glycol, ethanol, isopropanol (ketosis without acidosis), propylene glycol, mannitol. **Corrected Na⁺ for hyperglycemia** $$Na^+_{corr} = Na^+_{measured} + 1.6 \times \frac{Glucose - 100}{100}$$ (some use 2.4 when glucose > 400). Hyperglycemia pulls water out of cells → hypertonic hyponatremia. Don't confuse with pseudohyponatremia (hyperlipidemia/paraproteinemia, normal osmolality). **Corrected Ca²⁺ for albumin** $$Ca_{corr} = Ca_{measured} + 0.8 \times (4 - albumin)$$ Alkalosis ↑ albumin binding → ↓ ionized Ca (tetany with hyperventilation); acidosis does the opposite. ## F. Miscellaneous - **Cockcroft–Gault:** CrCl = [(140 − age) × weight (kg)] / (72 × S_Cr) × 0.85 if female. Used for drug dosing. - **CKD stages by GFR:** G1 ≥ 90; G2 60–89; G3a 45–59; G3b 30–44; G4 15–29; G5 < 15. - **BUN/Cr:** > 20 prerenal (↑ urea reabsorption with Na/water; also GI bleed, steroids, high-protein diet); 10–20 intrinsic. - **Spot urine protein/creatinine (mg/mg) ≈ g/day.** > 3.5 = nephrotic range. Albumin/Cr 30–300 mg/g = moderately increased (microalbuminuria). - **TTKG** = (U_K/P_K) ÷ (U_osm/P_osm). Hyperkalemia with TTKG < 7 → hypoaldosteronism; hypokalemia with TTKG > 4 → renal K⁺ wasting. (Lower yield, but it appears.) - **Na⁺ reabsorption by segment:** PCT ~67%, thick ascending limb ~25%, DCT ~5%, collecting duct ~3%. ## G. Normal values cheat sheet GFR 125 mL/min · RPF 650 · RBF 1,200 · FF 0.20 · urine flow ~1 mL/min · P_osm 275–295 · AG 8–12 · HCO₃⁻ 24 · PaCO₂ 40 · pH 7.40 · glucose threshold 200 mg/dL, Tm 375 ## H. Worked examples **1. Clearance & reabsorption:** P_x = 2 mg/mL, U_x = 100 mg/mL, V = 1 mL/min, GFR = 125. C_x = (100 × 1)/2 = 50 mL/min < GFR → net reabsorption. Reabsorption = (125 × 2) − (100 × 1) = 150 mg/min. **2. Hemodynamics:** C_inulin = 120, C_PAH = 600, Hct = 0.40. FF = 120/600 = 20%. RBF = 600/(1 − 0.4) = 1,000 mL/min (true RPF ≈ 600/0.9 ≈ 667). **3. Winter's:** pH 7.20, HCO₃⁻ 12, PaCO₂ 30. Expected PaCO₂ = 1.5(12) + 8 = 26 ± 2 → 24–28. Measured 30 is higher → **metabolic acidosis + respiratory acidosis**. **4. Corrected Na⁺:** Na⁺ 128, glucose 700. 128 + 1.6 × 6 = 137.6 → not truly hyponatremic; the hyponatremia is dilutional from glucose. **5. Delta ratio:** Na 140, Cl 95, HCO₃⁻ 10 → AG = 35. Δratio = (35 − 12)/(24 − 10) = 1.6 → pure HAGMA. (If HCO₃⁻ were 20: 23/4 = 5.75 → HAGMA + metabolic alkalosis.) ## I. Exam traps - **RTA vs. diarrhea:** both NAGMA + hypoK → only UAG separates them. - **Type 1 vs. 2:** both hypoK → urine pH (>5.5 vs <5.5), stones (type 1), Fanconi/rickets (type 2), alkali requirement. - **Type 4:** the only hyperkalemic one; think diabetes + ACEi/spironolactone/TMP. - **Creatinine clearance overestimates GFR; PAH clearance underestimates RPF.** - **Efferent constriction ↑ FF; efferent dilation ↓ FF; afferent changes leave FF unchanged.** - **Early CKD** → NAGMA (↓ ammoniagenesis, type-4-like); **advanced CKD** → HAGMA (retained sulfate, phosphate, urate).

explain me renal tubular acidosis and various renal formulas...